Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New sulfonamide derivatives as potent, selective and state-dependent Nav1.7 inhibitors for pain

July 14, 2020

Astrocytes, endocannabinoids, metabolism cooperate to affect behavior

July 13, 2020

Liver protein improves brain function after exercise

July 10, 2020

PTC Therapeutics begins first-in-human study of PTC-857 for GBA Parkinson's disease

July 10, 2020

Esteve Pharmaceuticals presents new analgesics

July 9, 2020

Calpain-2 in common, rare neurodegeneration

July 9, 2020

STK-001 studied for Dravet syndrome in new phase I/II study

July 8, 2020

Topline data presented from global phase II trial of SEP-4199 in bipolar I depression

July 8, 2020

First participant enrolled in phase I study of ANAVEX 3-71

July 7, 2020

ASO approach fixes myelin

July 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...